89 related articles for article (PubMed ID: 9613108)
21. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
[TBL] [Abstract][Full Text] [Related]
22. [Antisense oligodeoxynucleotides of human telomerse catalytic sub-unit inhibits telomerase activity and proliferation in SKOV3 and COC1].
Yuan B; Mi R
Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):198-201. PubMed ID: 12133408
[TBL] [Abstract][Full Text] [Related]
23. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
24. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
25. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
26. The evolving role of telomerase inhibitors in the treatment of cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(6):470-2. PubMed ID: 14594517
[TBL] [Abstract][Full Text] [Related]
27. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
28. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
Liu J; Timmers AM; Lewin AS; Hauswirth WW
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
[TBL] [Abstract][Full Text] [Related]
29. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.
Hao ZM; Luo JY; Cheng J; Wang QY; Yang GX
World J Gastroenterol; 2003 Jan; 9(1):104-7. PubMed ID: 12508361
[TBL] [Abstract][Full Text] [Related]
30. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cai DW; Mukhopadhyay T; Roth JA
Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
[TBL] [Abstract][Full Text] [Related]
31. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M
Cancer Res; 1998 Apr; 58(7):1558-61. PubMed ID: 9537264
[TBL] [Abstract][Full Text] [Related]
32. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
33. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
Rubiś B; Półrolniczak A; Rybczyńska M
Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
[TBL] [Abstract][Full Text] [Related]
34. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.
Müller-Kuller T; Capalbo G; Klebba C; Engels JW; Klein SA
Oligonucleotides; 2009 Sep; 19(3):265-72. PubMed ID: 19732019
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme].
Kong XJ; Lin JS; Song YH; Shen X; Jin YX
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):722-4. PubMed ID: 14697131
[TBL] [Abstract][Full Text] [Related]
37. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
[TBL] [Abstract][Full Text] [Related]
38. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
Tang J; Breaker RR
RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
[TBL] [Abstract][Full Text] [Related]
39. Construction, modification and evaluation of apolipoprotein A-I promoter-driven shRNA expression vectors against hTERT.
Ren X; Ma Y; Xu M; Chen T; Zhang Z; Zhang Y
Plasmid; 2011 Jan; 65(1):42-50. PubMed ID: 21087625
[TBL] [Abstract][Full Text] [Related]
40. [Preparation and identification of activity of antiplatelet-derived growth factor receptor beta subunit hammerhead ribozyme in vitro].
Lu C; Chen Y; Zhang Z; Wen L; Guo Y; Zhang X; Jin Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):288-90. PubMed ID: 11676875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
